CVE-2026-14996

CVE-2026-14996 is a high-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 8.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-613.

Key facts

Description

IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 has addressed a vulnerability related to session management.

Frequently asked questions

What is CVE-2026-14996?
IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 has addressed a vulnerability related to session management.
How severe is CVE-2026-14996?
CVE-2026-14996 has a CVSS 3.x base score of 8.2, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity low, and availability none.
Is CVE-2026-14996 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (13th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-14996?
CVE-2026-14996 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-14996?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-14996 published?
CVE-2026-14996 was published on 2026-07-28 and last updated on 2026-08-05.

References

Affected products (1)

More vulnerabilities in Ibm Aspera Faspex

All CVEs affecting Ibm Aspera Faspex →

Other CWE-613 (Insufficient Session Expiration) vulnerabilities

Browse all CWE-613 (Insufficient Session Expiration) vulnerabilities →